Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Briggs

Showing results (31-40 of 47) with videos related to

Pageof 5
Sort By:
Journal of Cardiovascular Pharmacology|June 1, 1993
ICI D7288, a novel sinoatrial node modulatorP W Marshall, W Rouse, I Briggs, et al.
Endocrinology|January 12, 2013
Calorie-restricted weight loss reverses high-fat diet-induced ghrelin resistance, which contributes to rebound weight gain in a ghrelin-dependent mannerDana I Briggs, Sarah H Lockie, Qunli Wu, et al.
Journal of Medicinal Chemistry|July 1, 1986
Antagonists of substance P. Further modifications of substance P antagonists obtained by replacing either positions 7, 9 or 7, 8 and 11 of SP with D-amino acid residuesA S Dutta, J J Gormley, A S Graham, et al.
Journal of Medicinal Chemistry|July 1, 1986
Analogues of substance P. Peptides containing D-amino acid residues in various positions of substance P and displaying agonist or receptor selective antagonist effectsA S Dutta, J J Gormley, A S Graham, et al.
Journal of Neuroscience Methods|September 21, 2011
A mouse model of human repetitive mild traumatic brain injuryMichael J Kane, Mariana Angoa-Pérez, Denise I Briggs, et al.
Neurotoxicology|January 1, 1997
L-2-chloropropionic acid inhibits glutamate and aspartate release from rat cerebellar slices but does not activate cerebellar NMDA receptors: implications for L-2-chloropropionic acid-induced neurotoxicityP S Widdowson, I Briggs, R E BoSmith, et al.
Journal of Neurochemistry|March 29, 2014
Animal models of sports-related head injury: bridging the gap between pre-clinical research and clinical realityMariana Angoa-Pérez, Michael J Kane, Denise I Briggs, et al.
Pflugers Archiv : European Journal of Physiology|January 1, 1989
A comparison of the effects and interactions of cromakalim and glibenclamide in cardiac and vascular tissuesR E BoSmith, I Briggs, T L Grant, et al.
International Journal of Molecular Sciences|November 30, 2018
Intracerebral Delivery of Brain-Derived Neurotrophic Factor Using HyStem<sup>®</sup>-C Hydrogel Implants Improves Functional Recovery and Reduces Neuroinflammation in a Rat Model of Ischemic StrokeKristine Ravina, Denise I Briggs, Sezen Kislal, et al.
ACS Chemical Neuroscience|August 5, 2014
Mice genetically depleted of brain serotonin do not display a depression-like behavioral phenotypeMariana Angoa-Pérez, Michael J Kane, Denise I Briggs, et al.
Pageof 5

Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
Journal of Cardiovascular Pharmacology|June 1, 1993
ICI D7288, a novel sinoatrial node modulatorP W Marshall, W Rouse, I Briggs, et al.
Endocrinology|January 12, 2013
Calorie-restricted weight loss reverses high-fat diet-induced ghrelin resistance, which contributes to rebound weight gain in a ghrelin-dependent mannerDana I Briggs, Sarah H Lockie, Qunli Wu, et al.
Journal of Medicinal Chemistry|July 1, 1986
Antagonists of substance P. Further modifications of substance P antagonists obtained by replacing either positions 7, 9 or 7, 8 and 11 of SP with D-amino acid residuesA S Dutta, J J Gormley, A S Graham, et al.
Journal of Medicinal Chemistry|July 1, 1986
Analogues of substance P. Peptides containing D-amino acid residues in various positions of substance P and displaying agonist or receptor selective antagonist effectsA S Dutta, J J Gormley, A S Graham, et al.
Journal of Neuroscience Methods|September 21, 2011
A mouse model of human repetitive mild traumatic brain injuryMichael J Kane, Mariana Angoa-Pérez, Denise I Briggs, et al.
Neurotoxicology|January 1, 1997
L-2-chloropropionic acid inhibits glutamate and aspartate release from rat cerebellar slices but does not activate cerebellar NMDA receptors: implications for L-2-chloropropionic acid-induced neurotoxicityP S Widdowson, I Briggs, R E BoSmith, et al.
Journal of Neurochemistry|March 29, 2014
Animal models of sports-related head injury: bridging the gap between pre-clinical research and clinical realityMariana Angoa-Pérez, Michael J Kane, Denise I Briggs, et al.
Pflugers Archiv : European Journal of Physiology|January 1, 1989
A comparison of the effects and interactions of cromakalim and glibenclamide in cardiac and vascular tissuesR E BoSmith, I Briggs, T L Grant, et al.
International Journal of Molecular Sciences|November 30, 2018
Intracerebral Delivery of Brain-Derived Neurotrophic Factor Using HyStem<sup>®</sup>-C Hydrogel Implants Improves Functional Recovery and Reduces Neuroinflammation in a Rat Model of Ischemic StrokeKristine Ravina, Denise I Briggs, Sezen Kislal, et al.
ACS Chemical Neuroscience|August 5, 2014
Mice genetically depleted of brain serotonin do not display a depression-like behavioral phenotypeMariana Angoa-Pérez, Michael J Kane, Denise I Briggs, et al.
Pageof 5